Sane completes move to Bayern from Manchester City    Lebanon's IMF talks on hold, finance minister says    "Liberate Hong Kong, revolution of our times" slogan is illegal, government says    Greece starts clearing ground for Athens property plan after long delay    Dr. Fauci: coronavirus may have mutated to become more infections    Russia's mortality rate up 1.5-2% since start of 2020    Egypt developing four WHO-registered vaccines to treat coronavirus patients    Egypt shuts down Cairo's famous Al-Hussein Mosque as anti-coronavirus rules violated    313 tourists from Switzerland, Belarus arrive in Egypt following flight resumption    Real Madrid close in on La Liga title after edging Getafe    Ethiopia intransigent on GERD issue: ECES seminar experts    AU-brokered talks over GERD to resume in next few days: Sudan    ABB, Hitachi launch $10bn joint power venture    Qalaa Holdings records 191% y-o-y increase in revenues during Q1 of 2020    Egypt's coronavirus cases surpass 70,000 infections    Thousands of Greeks protest against bill to regulate demonstrations    Sharm El Sheikh, Hurghada receive 313 tourists from Switzerland, Belarus    NCW calls for investigating harassment and rape allegations discussed on social media    Egypt's National Election Committee to announce Senate election details    Egypt is developing 4 vaccines, 3 drugs against COVID-19: Higher Education Minister    Japan's capital sees biggest rise in coronavirus cases in two months    Fire breaks out at Iranian nuclear facility, no damage reported, officials say    Live score: Manchester City v Liverpool (English Premier League)    Home prices in UK decline for the first time since 2012    Italy's Eni unveils new gas discovery off Egyptian Nile Delta coast    Egypt's parliament Oks supplementary spending bill for FY20    Egypt's Zamalek to continue training Thursday, but domestic league participation unclear    Apple to re-close more stores in U.S, bringing total to 77    Twitter removes image tweeted by U.S. President Trump from its platform    Egypt's Court of Cassation upholds death penalty for 3 defendants in Ansar Al-Sharia case    Liverpool boss Klopp happy with African Nations Cup postponement    Deadly protests erupt in Ethiopia over killing of popular Oromo singer    Egypt's cultural activities to resume mid-July    At 99, CPC governance legitimacy shines brighter in time of global uncertainty    Federation of Egyptian Banks denies funding GERD: eletreby    Saudi development authority starts executing phase I of giant cultural project    Reopening the Baron's Palace    30 June Revolution preserved Egyptian identity from hijack: Al-Sisi    2 dangerous militants neutralised in North Sinai: Interior Ministry    Don't miss Al-Hadra troupe's two concerts at El-Sawy Culturewheel    Egypt's President Sisi opens Baron Empain Palace, two int'l airports    Inauguration of Baron Empain Palace important for Egypt's tourism sector: official    President Al-Sisi inaugurates new national project developments in Cairo    11 coronavirus cases detected at Egyptian Premier League clubs – EFA    Egypt to host World Handball Championship on time despite COVID-19: EHF President    Liverpool's Egyptian winger Salah fit for Crystal Palace clash – coach Klopp    Egypt's parliament Oks amendments to House law amid differences over election    CAF draws timeline for resumed continental championships amid COVID-19    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





Scientists in new push to control cancer before curing it
Published in Ahram Online on 19 - 05 - 2019

Cancer scientists in Britain are launching what they call the world's first “Darwinian” drug development program in a bid to get ahead of cancer's ability to become resistant to even the newest treatments and recur in many patients.
While not abandoning the search for an ultimate cure, the “anti-evolution” project will re-focus on turning cancer into a disease controllable with drugs for many years.
This would be a little like HIV, the virus that causes AIDS, the scientists told reporters at a briefing.
“Cancer's ability to adapt, evolve and become drug-resistant is the cause of the vast majority of deaths from the disease and the biggest challenge we face in overcoming it,” said Paul Workman, chief executive of Britain's Institute of Cancer Research (ICR) - a charity and research institute which will lead the new Centre for Cancer Drug Discovery.
The centre, funded with 75 million pounds ($96.5 million) from the ICR, will “seek to meet the challenge of cancer evolution head on”, Workman said, by blocking its process of evolution.
Teams at the new centre will initially focus on two possible paths to doing this.
The first, known as “evolutionary herding”, involves selecting an initial specific treatment that forces cancer cells to adapt in a way that makes them highly susceptible to a second drug, or pushes them into an evolutionary dead end.
The second will explore a possible new class of drugs to target cancer's ability to evolve and become resistant to treatment. These potential drugs would be designed to block the action of molecules called APOBEC proteins, found in the body's immune system.
Researchers hope a new class of APOBEC inhibitors could be developed and given alongside targeted cancer treatments to try and keep cancer at bay for much longer.
Combination therapies using multiple current or new treatments will also be explored, Workman said.
Olivia Rossanese, a specialist in cancer drug discovery who will head the new centre's biology team, said the idea was to build a global hub of expertise in anti-evolution therapies so scientists could “stop playing catch-up” with cancer.
“This Darwinian approach to drug discovery gives us the best chance yet of defeating cancer,” she said, “because we will be able to predict what cancer is going to do next and get one step ahead.”


Clic here to read the story from its source.